All treatments
Treatment
Mexiletine granules for prolonged-release oral suspension clinical trials
2 indexed studies · 2 currently recruiting
- Enrolling by invitationPHASE3
An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 Who Have Completed MEX-DM-302 Study.
This study looks at the long-term safety and effectiveness of a drug called mexiletine for people with Myotonic Dystrophy Type 1 or Type 2. It's for those who have already completed a previous study with this medication.
For: Myotonic DystrophyBelgium · Denmark · Germany - RecruitingPHASE3
The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2
This study is testing a new form of mexiletine, a medicine, for people with Myotonic Dystrophy Types 1 and 2. It will compare the new medicine to a dummy pill (placebo) to see if it helps with muscle problems and if it's safe. It lasts for 26 weeks.
For: Myotonic DystrophyBelgium · Denmark · Germany